InvestorsHub Logo
icon url

Jasbg

09/09/20 3:42 PM

#297759 RE: shadolane #297752

Sometimes hard to understand how the market reacts.

AMRN, and Vascepa bin in the market with a product since 2012. Now have an important extended approval (R-I) that expands the potential market to hundred of millions WW.
Amarin sales exceeding 1 billion dollars (july 2019 - july 2020)
Europe - China coming up.

SP this moment $ 4.20. (max ever. $ 26.12)
------------------------------------------

Comparison: (the stock Baker Brothers bought when reducing AMRN by 7 mill shares - some time back)

https://finance.yahoo.com/quote/IFRX?p=IFRX&.tsrc=fin-srch

IFRX = Status Level 2b trials - no product on the market.

SP this moment $ 3.90 (recently above $ 8.00) - (max. SP ever $ 50.50)
-------------------------------------------

Makes you wonder how these two stocks can be valued about the same - even the setback of patent loss in US market for Marine.

Jasbg